- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Pie Medical Imaging Launches AI-Powered Echocardiography Platform
CAAS Qardia 2.0, an updated version of the CAAS Qardia echocardiography software platform, reportedly incorporates artificial intelligence (AI)-enabled workflows, and provides enhanced imaging and analysis of key cardiac measures.
Combining off-cart echocardiography analysis with artificial intelligence (AI) capabilities, Pie Medical Imaging has launched the FDA-cleared CAAS Qardia 2.0 platform.
An update to the company’s CAAS Qardia echocardiography software, the CAAS Qardia 2.0 software offers robust visualization of stress-echo imaging and diastolic function, and reportedly excels at analysis of myocardial strain and other cardiac assessments, according to Pie Medical Imaging.
The company notes that quality control indices with the CAAS Qardia 2.0 platform enable clinicians to counteract potential foreshortening of cardiac imaging that may impact measurements such as myocardial strain. Leveraging AI-powered workflows, the CAAS Qardia 2.0 software generates automated reporting of key parameters.
Pie Medical imaging adds that the CAAS Qardia software can be server-based with access from any PC within a hospital network or be deployed in a stand-alone setup.
(Editor's note: For a related article, see "FDA Clears AI-Powered Echocardiography Platform for Detecting Heart Failure with Preserved Ejection Fraction.")
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.
